医学
合生元
腹泻
随机对照试验
重症监护医学
系统回顾
肠内给药
梅德林
内科学
漏斗图
临床试验
出版偏见
荟萃分析
致盲
布拉迪酵母菌
相对风险
报告审判综合标准
分级(工程)
证据质量
置信区间
风险评估
儿科
抗生素相关性腹泻
代理终结点
随机化
循证医学
并发症
作者
Shan Wu,Lu Yao,田周林,Runfa You
摘要
BACKGROUND: Diarrhea is a frequent complication during enteral nutrition (EN) in adults and may interrupt feeding, prolong hospitalization, and increase healthcare burden. Modulation of the intestinal microbiota with probiotics or synbiotics represents a potential preventive strategy, but the evidence remains uncertain. METHODS: This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines (PROSPERO: CRD420251183554). We searched PubMed, Embase, the Cochrane Library, Web of Science, CNKI, Wanfang, and CQVIP from database inception to November 6, 2025. Randomized controlled trials (RCTs) comparing prophylactic probiotics or synbiotics with placebo, routine care, or unsupplemented EN in adults were eligible. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random-effects models. Certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. RESULTS: = 0% may reflect limited power with sparse events. Funnel plot asymmetry and Egger's test (p < 0.001) suggested possible publication bias. Most trials had high risk of bias (unblinded outcome assessment). Certainty was very low, downgraded mainly for serious risk of bias and suspected publication bias. CONCLUSIONS: Very low-certainty evidence suggests probiotics or synbiotics may reduce reported diarrhea in adults on EN, but the true effect is likely smaller. Current data do not support routine use or specific recommendations. Larger, blinded trials with standardized definitions are needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI